← Back to Search

Family-Focused Therapy for Psychosis

N/A
Recruiting
Led By Holly K. Hamilton, Ph.D.
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Must not have
Impaired intellectual functioning (IQ<70)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0, 6, 12, and 18 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is to see if Family Focused Therapy is an effective treatment for psychosis in young people.

Who is the study for?
This trial is for English-speaking youth aged 13-25 at high risk for psychosis, who have a parent or guardian involved in their life and can consent to treatment. Participants must show early signs of psychosis but cannot have a full psychotic disorder, severe substance abuse issues, or intellectual impairment.
What is being tested?
The study tests Family Focused Therapy (FFT-CHR) against Enhanced Care (EC) in young individuals showing early symptoms of psychosis. The participants will be monitored every six months over an 18-month period by established clinical research programs.
What are the potential side effects?
As this trial involves therapy sessions rather than medication, typical side effects associated with drugs are not expected. However, discussing mental health can sometimes cause temporary discomfort or emotional distress.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My IQ is below 70.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0, 6, 12, and 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0, 6, 12, and 18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
The Structured Interview for Psychosis-risk Syndromes Scale of Prodromal Symptoms (SOPS)
Secondary study objectives
Appraisal of Family Interactions
Calgary Depression Scale for Schizophrenia
Family Interactional Assessment Task
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: FFT-CHRExperimental Treatment1 Intervention
Family-Focused Therapy for Clinical High-Risk Individuals
Group II: Enhanced CareActive Control1 Intervention
Enhanced Care Psychoeducation for Clinical High-Risk Individuals

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,936 Previous Clinical Trials
2,741,822 Total Patients Enrolled
47 Trials studying Psychosis
10,573 Patients Enrolled for Psychosis
University of California, Los AngelesLead Sponsor
1,569 Previous Clinical Trials
10,314,075 Total Patients Enrolled
7 Trials studying Psychosis
1,950 Patients Enrolled for Psychosis
Holly K. Hamilton, Ph.D.Principal InvestigatorUniversity of California, San Francisco
David J. Miklowitz, Ph.D.Principal Investigator - University of California, Los Angeles
University of California, Los Angeles
1 Previous Clinical Trials
39 Total Patients Enrolled
Kristin S. Cadenhead, M.D.Principal InvestigatorUniversity of California, San Diego
Scott Woods, M.D.Principal InvestigatorYale University
3 Previous Clinical Trials
2,747 Total Patients Enrolled
1 Trials studying Psychosis
2,617 Patients Enrolled for Psychosis
Jean M. Addington, Ph.D.Principal InvestigatorUniversity of Calgary
Andrea M. Auther, Ph.D.Principal InvestigatorZucker Hillside Hospital at Hofstra / Northwell Health
Barbara A. Cornblatt, Ph.D., M.B.A.Principal InvestigatorHofstra University / Northwell Health
Daniel H. Mathalon, Ph.D., M.D.Principal InvestigatorUniversity of California, San Francisco

Media Library

Family Focused Therapy for Clinical High Risk Youth (FFT-CHR) Clinical Trial Eligibility Overview. Trial Name: NCT04338152 — N/A
Psychosis Research Study Groups: Enhanced Care, FFT-CHR
Psychosis Clinical Trial 2023: Family Focused Therapy for Clinical High Risk Youth (FFT-CHR) Highlights & Side Effects. Trial Name: NCT04338152 — N/A
Family Focused Therapy for Clinical High Risk Youth (FFT-CHR) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04338152 — N/A
~25 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top